Diazoxide - CAS 364-98-7
Catalog number:
B0084-474147
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C8H7ClN2O2S
Molecular Weight:
230.66
COA:
Inquire
Targets:
Potassium Channel
Description:
Diazoxide is a benzothiadiazine derivative which acts as a potassium channel activator.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-474147 2 g $199 In stock
Bulk Inquiry
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
potassium channel activator
Purity:
≥98%
Appearance:
White Solid
Synonyms:
7-chloro-3-methyl-4H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide
Solubility:
Soluble in DMSO
Storage:
Store at 2-8 °C
MSDS:
Inquire
Application:
Diazoxide reduces status epilepticus neuron damage in diabetes.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Milligrams-Grams
Melting Point:
>300°C
Density:
1.61g/cm3
InChIKey:
GDLBFKVLRPITMI-UHFFFAOYSA-N
InChI:
InChI=1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11)
Canonical SMILES:
CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl
Current Developer:
Mercury
1.Impaired glucose-stimulated insulin secretion and reduced beta cell mass in pancreatic islets of hyperthyroid rats.
Karbalaei N1,2, Noorafshan A1, Hoshmandi E2. Exp Physiol. 2016 Apr 6. doi: 10.1113/EP085627. [Epub ahead of print]
To clarify mechanism behind the effect of thyroid hormone excess on pancreatic insulin secretion and abnormal glucose tolerance induced by hyperthyroidism, we investigated the effect of hyperthyroidism on the pancreatic beta cell mass and two key components of insulin secretion pathway, ATP-sensitive K+ (KATP) and L-type Ca2+ channels. In the control and levothyroxine-treated hyperthyroid rats, intraperitoneal glucose tolerance test (IPGTT) was performed and insulin secretion and content of the isolated islets were assayed. In order to determine the effect of hyperthyroidism on KATP and L-type Ca2+ channels, isolated islets were exposed to specific pharmacological drugs including glibenclamide (KATP channel blocker), diazoxide (KATP channel opener), and nifedipine (L-type Ca2+ channel blocker). Histomorphometric changes and histochemistry of the islet in both groups were compared. Our data indicated that plasma glucose and insulin concentrations during IPGTT in the hyperthyroid group was respectively higher and lower than the controls.
2.Isosteviol Sensitizes sarcKATP Channels towards Pinacidil and Potentiates Mitochondrial Uncoupling of Diazoxide in Guinea Pig Ventricular Myocytes.
Fan Z1, Wen T2, Chen Y2, Huang L2, Lin W2, Yin C2, Tan W1. Oxid Med Cell Longev. 2016;2016:6362812. doi: 10.1155/2016/6362812. Epub 2016 Feb 2.
KATP channel is an important mediator or factor in physiological and pathological metabolic pathway. Activation of KATP channel has been identified to be a critical step in the cardioprotective mechanism against IR injury. On the other hand, desensitization of the channel to its opener or the metabolic ligand ATP in pathological conditions, like cardiac hypertrophy, would decrease the adaption of myocardium to metabolic stress and is a disadvantage for drug therapy. Isosteviol, obtained by acid hydrolysis of stevioside, has been demonstrated to play a cardioprotective role against diseases of cardiovascular system, like anti-IR injury, antihypertension, antihyperglycemia, and so forth. The present study investigated the effect of isosteviol (STV) on sarcKATP channel current induced by pinacidil and mitochondrial flavoprotein oxidation induced by diazoxide. Our results showed that preincubating cells with STV not only increased the current amplitude and activating rate of sarcKATP channels induced by pinacidil but also potentiated diazoxide-elicited oxidation of flavoprotein in mitochondria.
3.Depolarization of Mitochondria in Neurons Promotes Activation of Nitric Oxide Synthase and Generation of Nitric Oxide.
Katakam PV1, Dutta S2, Sure VN2, Grovenburg SM2, Gordon AO2, Peterson NR2, Rutkai I2, Busija DW2. Am J Physiol Heart Circ Physiol. 2016 Mar 4:ajpheart.00759.2015. doi: 10.1152/ajpheart.00759.2015. [Epub ahead of print]
The diverse signaling events following mitochondrial depolarization in neurons are not clear. We examined for the first time the effects of mitochondrial depolarization on mitochondrial function, intracellular calcium, neuronal nitric oxide synthase (nNOS) activation, and nitric oxide (NO) production in cultured neurons and perivascular nerves. Cultured rat primary cortical neurons were studied on 7-10 days in vitro and endothelium-denuded cerebral arteries of adult Sprague Dawley rats were studied ex vivo. Diazoxide and BMS-191095 (BMS), activators of mitochondrial KATP channels, depolarized mitochondria in cultured neurons and increased cytosolic calcium levels. However, mitochondrial oxygen consumption rate was unaffected by mitochondrial depolarization. In addition, diazoxide and BMS not only increased the nNOS phosphorylation at positive regulatory serine 1417 but also decreased nNOS phosphorylation at negative regulatory serine 847.
4.Rosuvastatin Treatment Affects Both Basal and Glucose-Induced Insulin Secretion in INS-1 832/13 Cells.
Salunkhe VA1, Elvstam O1, Eliasson L1, Wendt A1. PLoS One. 2016 Mar 17;11(3):e0151592. doi: 10.1371/journal.pone.0151592. eCollection 2016.
Rosuvastatin is a member of the statin family. Like the other statins it is prescribed to lower cholesterol levels and thereby reduce the risk of cardiovascular events. Rosuvastatin lowers the cholesterol levels by inhibiting the key enzyme 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase) in the cholesterol producing mevalonate pathway. It has been recognized that apart from their beneficial lipid lowering effects, statins also exhibit diabetogenic properties. The molecular mechanisms behind these remain unresolved. To investigate the effects of rosuvastatin on insulin secretion, we treated INS-1 832/13 cells with varying doses (20 nM to 20 μM) of rosuvastatin for 48 h. At concentrations of 2 μM and above basal insulin secretion was significantly increased. Using diazoxide we could determine that rosuvastatin did not increase basal insulin secretion by corrupting the KATP channels. Glucose-induced insulin secretion on the other hand seemed to be affected differently at different rosuvastatin concentrations.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Potassium Channel Products


CAS 448895-37-2 NS 1643

NS 1643
(CAS: 448895-37-2)

NS 1643 is human ether-a-go-go related gene (hERG) KV11.1 channel activator (EC50 = 10.5 μM)

CAS 207844-01-7 Mitiglinide calcium hydrate

Mitiglinide calcium hydrate
(CAS: 207844-01-7)

Mitiglinide calcium hydrate, a derivative of benzylsuccinic acid, is a highly selective KATP channel antagonist.

CAS 94535-50-9 Levcromakalim

Levcromakalim
(CAS: 94535-50-9)

LevCromakalim is an ATP-sensitive K+channel(KATP) activator used in the management of hypertension in diabetes mellitus.

BMS-919373
(CAS: 1272353-82-8)

This active molecular is a Kv1.5 potassium channel inhibitor originated by Bristol-Myers Squibb. Treatment for paroxysmal atrial fibrillation is in Phase II cli...

PF-05020182
(CAS: 1354712-92-7)

PF05020182 is novel potent and selective Kv7.2/4 potassium channel opener originated by Pfizer. It can inhibit convulsions in the MES assay at doses tested, con...

CAS 748810-28-8 Vernakalant hydrochloride

Vernakalant hydrochloride
(CAS: 748810-28-8)

Vernakalant hydrochloride, also known as RSD1235, is a novel, relatively atrial-selective antiarrhythmic drug which can terminate acute atrial fibrillation (AF)...

CAS 166095-21-2 BMS-191095

BMS-191095
(CAS: 166095-21-2)

BMS-191095 is an activators that has selective effects on mitochondrial ATP-sensitive potassium (mitoKATP) channels. in vitro: induces mitochondrial-depolarizat...

ML277
(CAS: 1401242-74-7)

ML277, a sulfonylpiperidine compound, has been found to be a KCNQ1 K+ channel activator and could be used in the study of the activity of K+ channel in human ca...

CAS 149908-53-2 Azimilide

Azimilide
(CAS: 149908-53-2)

Azimilide, also called as Stedicor, a chlorophentlturany compound, inhibits I(Ks) and I(Kr) in guinea-pig cardiac myocytes and I(Ks) (minK) channels. Phase III

CAS 10238-21-8 Glyburide (Glibenclamide)

Glyburide (Glibenclamide)
(CAS: 10238-21-8)

Glyburide (Glibenclamide) is an anti-diabetic compound in a class of medications known as sulfonylureas, closely related to sulfa agents.

CAS 51940-44-4 Pipemidic acid

Pipemidic acid
(CAS: 51940-44-4)

Pipemidic acid is a synthetic quinolone antibiotic agent as a ATP-sensitive K+ channel blocker.

GYKI-16638
(CAS: 778564-77-5)

GYKI-16638 is Potassium channel and Sodium channel antagonist originated by Nonindustrial source. It is a novel antiarrhythmic agent.

NS6180
(CAS: 353262-04-1)

NS6180 is a potent KCa3.1 channel blocker (IC50 values are 9, 14 and 15 nM for rat, human and mouse erythrocyte KCa3.1 channels respectively). NS6180 prevents T...

ML-365
(CAS: 947914-18-3)

ML-365 is a potent and novel selective small molecule inhibitor of TASK1 with IC50 of 4 nM(thallium influx fluorescent assay) and 16 nM(automated electrophysiol...

CAS 33400-45-2 Flupirtine Hydrochloride

Flupirtine Hydrochloride
(CAS: 33400-45-2)

Flupirtine is an agonist of Kv7 potassium (KCNQ) channels, doubles channel currents when applied at 10 µM.

CAS 65141-46-0 Nicorandil

Nicorandil
(CAS: 65141-46-0)

Nicorandil is potassium channel activator.

CAS 50679-08-8 Terfenadine

Terfenadine
(CAS: 50679-08-8)

Terfenadine is a potent open-channel blocker of hERG (IC50=204 nM), formerly used for the treatment of allergic conditions.

Endoxifen HCl
(CAS: 1032008-74-4)

Endoxifen HCl, the active metabolite of Tamoxifen, ia a potent and selective estrogen receptor antagonist. Phase 2. Endoxifen shows anti-estrogenic effects, and...

CAS 489402-47-3 ML213

ML213
(CAS: 489402-47-3)

ML213 is a selective activator of KCNQ2 (Kv7.2) and KCNQ4 (Kv7.4) with > 80-fold selectivity against other related K+ channels, and enhances Kv7.2 and Kv7.4 cha...

CAS 184653-84-7 Carabersat

Carabersat
(CAS: 184653-84-7)

Carabersat, also called as SB 204269, an orally-effective anticonvulsant agent, is an ATP-sensitive potassium channel (K-ATP) opener with potential effect to t...

Chemical Structure

CAS 364-98-7 Diazoxide

Quick Inquiry

Verification code

Featured Items